InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )
Clinical trial NCT04442178 · TERMINATED
Trial details
- NCT number
- NCT04442178
- Sponsor
- Revimmune
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2022-03-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.